APC, an Irish pharmaceutical research company and a spin-out from University College Dublin (UCD), has announced the creation of 100 jobs. The announcement was made as the company’s new state-of-the-art process research facility in Cherrywood, Dublin, was officially opened. The 6,000-sq-m premises will also serve as APC’s new headquarters. APC is an innovator in process research solutions for the drugs industry and helps global clients accelerate the development of their medicines for a range of conditions including cancer and HIV. The company’s move to Cherrywood Business Park is part of its expansion as it looks to more than double its workforce to meet client demand. Established by Professor Brian Glennon and Dr Mark Barrett in 2011, APC is as a spin-out from the UCD School of Chemical and Bioprocess Engineering. The company won the NovaUCD 2011 Start-up of the Year Award after being declared overall winner of the 16^th NovaUCD Campus Company Development Programme, the forerunner of the current UCD VentureLaunch Accelerator Programme. In the space of four years, the company has pioneered innovation in the pharmaceutical sector and now partners with eight of the top 10 pharma and five of the top 10 biotech firms in the world. A total of 80 per cent of its services are export-driven and the company aims to reach revenues of €50 million by 2020. “Our success has come from working with talented and creative engineers and scientists. We are looking to expand the team with today's announcement of 100 highly skilled research and development jobs across chemical engineering, sciences and analytics,” said Dr Mark Barrett, APC CEO. “We need people who enjoy the rewards of working in an environment that is driven by cutting-edge technology and science. In return, we will provide them with an opportunity to do something extraordinary: to help change patient outcomes for the better,” he added.